Dimensional Fund Advisors
CRBU icon

Dimensional Fund Advisors’s Caribou Biosciences CRBU Stock Holding History

Dimensional Fund Advisors’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$951K Sell
748,734
-226,593
-23% -$354K ﹤0.01% 2840
2026
Q2 		$1.72M Buy
975,327
+302,127
+45% +$597K ﹤0.01% 2769
2026
Q1 		$1.28M Sell
673,200
-332,810
-33% -$571K ﹤0.01% 2796
2025
Q4 		$1.6M Sell
1,006,010
-204,300
-17% -$429K ﹤0.01% 2774
2025
Q3 		$2.82M Sell
1,210,310
-97,045
-7% -$183K ﹤0.01% 2676
2025
Q2 		$1.65M Sell
1,307,355
-77,314
-6% -$76K ﹤0.01% 2810
2025
Q1 		$1.26M Sell
1,384,669
-347,709
-20% -$452K ﹤0.01% 2826
2024
Q4 		$2.75M Sell
1,732,378
-321,867
-16% -$647K ﹤0.01% 2709
2024
Q3 		$4.03M Sell
2,054,245
-569,038
-22% -$1.17M ﹤0.01% 2577
2024
Q2 		$4.3M Buy
2,623,283
+536,162
+26% +$1.71M ﹤0.01% 2538
2024
Q1 		$10.7M Buy
2,087,121
+736,337
+55% +$4.54M ﹤0.01% 2282
2023
Q4 		$7.74M Buy
1,350,784
+757,107
+128% +$3.74M ﹤0.01% 2423
2023
Q3 		$2.84M Buy
593,677
+462,997
+354% +$2.87M ﹤0.01% 2679
2023
Q2 		$555K Sell
130,680
-82,603
-39% -$371K ﹤0.01% 3042
2023
Q1 		$1.13M Buy
+213,283
New +$1.33M ﹤0.01% 2876

Other funds holding CRBU

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Pfizer
Pfizer New York $164M AUM 53.62% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $91.6B AUM 30% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $123B AUM 30.05% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Dimensional Fund Advisors's CRBU Position: Q3 2026 in Review

Dimensional Fund Advisors reduced its Caribou Biosciences (CRBU) stake by 23% in Q3 2026, selling an estimated $354K and leaving 748,734 shares worth $951K. The position accounts for ﹤0.01% of the portfolio, ranked #2840.

Dimensional Fund Advisors first reported a position in CRBU in Q1 2023 and has held it in 15 quarters since. The position peaked at $10.7M in Q1 2024. 109 funds tracked by Wall St. Rank hold CRBU as of Q3 2026.

  • Dimensional Fund Advisors held 748,734 shares of Caribou Biosciences worth $951K as of Q3 2026.
  • Dimensional Fund Advisors sold 226,593 Caribou Biosciences shares in Q3 2026, an estimated $354K.
  • Caribou Biosciences made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q3 2026, its #2840 holding.
  • Dimensional Fund Advisors first reported a position in Caribou Biosciences in Q1 2023 and has held it in 15 quarters since.
  • Dimensional Fund Advisors's Caribou Biosciences position peaked at $10.7M in Q1 2024.
  • 109 funds tracked by Wall St. Rank held Caribou Biosciences as of Q3 2026.

Based on Dimensional Fund Advisors's 13F filing for Q3 2026, filed 4 Nov 2026.